SBL Dibonil tablets is indicated for maturity onset diabetes metllitus or non insulin dependent diabetes mellitus, increased frequency of urination, increased thirst, hyper-glycaemia (an excess of glucose in the bloodstream, often associated with diabetes mellitus), weakness, cramps.
SBL Dibonil is a product of SBL research and development and is combination of well proven drugs of homeopathic therapeutic which brings to prevent common diabetic problems, excessive urination, elevated blood sugar level.
Also it prevents boils sores and promoting metabolism activities. Dibonil is formulated with homeopathically proven drugs. Dibonil checks the commonly associated problems of diabetes and has no side effects. Therefore it can be prescribed for longer duration. Dibonil can be taken along with medicines also.
Dibonil from SBL is also available in drops form, check out details here
Ingredients of SBL Dibonil Tablets: SBL Dibonil Tablets Contains: Cephalandra Indica 3x, Gymnema Sylvestre 3x, Syzygium Jambolanum 3x, Crataegus Oxyacantha 3x, Acidum Phosphoricum 3x, Uranium Nitricum 3x.
SBL Dibonil Tablets Dosage: Adults 4 tablets of SBL Dibonil Tablets, 4-6 times daily
Contraindications of SBL Dibonil Tablets: No known contraindications of SBL Dibonil Tablets.
SBL Dibonil Tablets Side effects: No known side effects on prolonged use.
Presentation: SBL Dibonil Tablets comes in 25 gm and 450 gms
Manufacturer: SBL Pvt.Ltd
SBL is India’s prominent Homeopathic brand known for its quality & efficacy of medicines. SBL medicines undergo extensive clinical trials and are ISO 9000:2000 quality & GMP certified. The result is a product like SBL Dibonil Tablets that delivers the healing that it promises. SBL’s motto is “excellence at no extra cost”
Price/Rate: Rs.125/680 (Buy Online!! Get upto 15% OFF)
You can also conveniently order SBL Dibonil Tablets online by Mail, Phone or Whatsapp (#9686858499)
Online Order Form
If you have any question about SBL Dibonil Tablets or want advise on a medical condition requiring homeopathic treatment, please leave your comment below (in the comments section) and we will respond